Cholera vaccine candidate 638: intranasal immunogenicity and expression of a foreign antigen from the pulmonary pathogen Coccidioides immitis.
Vibrio cholerae strain 638 is a live genetically attenuated candidate cholera vaccine in which the CTXPhi prophage encoding cholera toxin has been deleted and hapA, encoding an extracellular Zn-dependent metalloprotease, was insertionally inactivated. Strain 638 was highly immunogenic when inoculated to adult Swiss mice by the intranasal route as judged by the induction of a strong serum vibriocidal antibody response. A side-by-side comparison of strain 638 with its isogenic hapA(+) precursor (strain 81) in the above model indicated that inactivation of hapA does not affect immunogenicity. The spherule-associated antigen 2/proline-rich antigen (Ag2/PRA) of Coccidioides immitis has been shown to protect mice against coccidioidomycosis to an extent dependent on the modes of antigen presentation and challenge with C. immitis arthrospores. In this work, we demonstrate the use of a live genetically attenuated V. cholerae strain to deliver Ag2/PRA. Ag2/PRA was expressed in 638 as a fusion protein with the Escherichia coli heat labile toxin B subunit leader peptide using the strong Tac promoter. The recombinant Ag2/PRA was efficiently expressed, processed and secreted to the periplasmic space. Intranasal immunizations of adult mice with strain 638 expressing Ag2/PRA induced serum vibriocidal antibody response to the vector strain and serum total IgG response to Ag2/PRA. Strain 638 expressing PRA could be recovered from trachea and lung up to 20h after immunization but was effectively cleared 72h post-inoculation.
Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, 720 Westview Drive SW, Atlanta, GA 30310-1495, USA.
Anisia J
AJ
Silva
Archana
A
Mohan
Jorge A
JA
Benitez
D000281:Administration, Intranasal; D000818:Animals; D000946:Antigens, Fungal / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D022121:Cholera Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D003045:Coccidioides / Q000235:genetics / Q000276:immunology*; D003047:Coccidioidomycosis / Q000276:immunology* / Q000517:prevention & control; D005656:Fungal Proteins; D006023:Glycoproteins / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D015151:Immunoblotting; D007074:Immunoglobulin G / Q000097:blood; D051379:Mice; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology; D014734:Vibrio cholerae / Q000235:genetics / Q000276:immunology*
D000946:Antigens, Fungal; D022121:Cholera Vaccines; D005656:Fungal Proteins; D006023:Glycoproteins; D007074:Immunoglobulin G; D014613:Vaccines, Attenuated; C102758:antigen 2, Coccidioides